Biocure Technology Inc. (CSE:CURE.X)
Canada
· Delayed Price · Currency is CAD 0.0350
0.00 (0.00%)
At close: Feb 26, 2026
Biocure Technology Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Selling, General & Admin | 0.24 | 0.32 | 0.34 | 0.67 | 0.57 | 1.34 | Upgrade
|
| Research & Development | - | - | - | - | - | 1.56 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | 0.01 | Upgrade
|
| Operating Expenses | 0.24 | 0.32 | 1.05 | 0.67 | 1.73 | 3.07 | Upgrade
|
| Operating Income | -0.24 | -0.32 | -1.05 | -0.67 | -1.73 | -3.07 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.01 | -0 | -0.06 | -0.24 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0 | Upgrade
|
| Earnings From Equity Investments | - | - | -0.18 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0 | -0 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | 0.06 | 0.05 | -0.02 | -0.07 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -0.28 | -0.26 | -1.19 | -0.7 | -1.87 | -3.29 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.74 | - | - | 0 | Upgrade
|
| Other Unusual Items | - | - | 0.43 | 0.3 | - | 0.21 | Upgrade
|
| Pretax Income | -0.28 | -0.26 | -1.49 | -0.4 | -1.87 | -3.08 | Upgrade
|
| Earnings From Continuing Operations | -0.28 | -0.26 | -1.49 | -0.4 | -1.87 | -3.08 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -0.35 | -1.11 | 0.72 | - | Upgrade
|
| Net Income to Company | -0.28 | -0.26 | -1.84 | -1.52 | -1.15 | -3.08 | Upgrade
|
| Minority Interest in Earnings | - | - | 0.03 | 0.06 | 0.02 | 0.13 | Upgrade
|
| Net Income | -0.28 | -0.26 | -1.81 | -1.45 | -1.13 | -2.95 | Upgrade
|
| Net Income to Common | -0.28 | -0.26 | -1.81 | -1.45 | -1.13 | -2.95 | Upgrade
|
| Shares Outstanding (Basic) | 20 | 10 | 10 | 12 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 10 | 10 | 12 | 11 | 11 | Upgrade
|
| Shares Change (YoY) | -70.41% | 1.23% | -13.15% | 3.76% | 4.98% | 1.25% | Upgrade
|
| EPS (Basic) | -0.01 | -0.03 | -0.18 | -0.12 | -0.10 | -0.27 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.03 | -0.18 | -0.12 | -0.10 | -0.27 | Upgrade
|
| Free Cash Flow | -0.08 | 0.01 | -0.22 | -0.83 | -1.08 | -1.31 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.00 | -0.02 | -0.07 | -0.10 | -0.12 | Upgrade
|
| EBITDA | - | - | - | -0.67 | -1.67 | -3.02 | Upgrade
|
| D&A For EBITDA | - | - | - | 0.01 | 0.06 | 0.04 | Upgrade
|
| EBIT | -0.24 | -0.32 | -1.05 | -0.67 | -1.73 | -3.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.